Emyria's pivotal role in PTSD research

Emyria Limited (ASX: $EMD) has entered into a binding research study agreement with charity Reach Wellness to manage a pivotal observational study designed to evaluate the effectiveness of Emyria's MDMA-assisted therapy (MDMA-AT) program for first responders with PTSD. Reach Wellness will subsidise costs of treatment for an initial cohort of 50 qualified first responders, amounting to an estimated total of $1.5 million, subject to fundraising.

Executive commentary on the partnership

First responders keep our communities safe and functioning both locally and overseas. However, these roles can be highly stressful both physically and mentally as is evident by the high rates of PTSD and other mental health challenges. Reach's mission is to fund research and care programs for those who help others first with the generous support of our donors. Emyria is one of the most well-prepared research organisations in Australia capable of evaluating MDMA-assisted therapy in real-world settings and we are excited to partner with them on this research program managed within a strictly controlled regulatory environment.

Summary of the pivotal research study

Emyria's partnership with Reach Wellness to manage a pivotal observational study for first responders with PTSD marks a significant step forward in addressing the unique care and support requirements of this group. The study aims to evaluate the Real-World efficacy and cost benefits of Emyria's MDMA-AT model combined with a tailored support program for an initial cohort of 50 first responders. The initiative represents a substantial pledge towards mental health care and will help evaluate the potential of new therapies for those who serve and protect us. The partnership also aims to support broader health service and payer engagement by demonstrating the safety, effectiveness, and scalability of Emyria's MDMA-AT model. Emyria's commitment to evaluating the impact of emerging approaches like MDMA-Assisted Therapy aligns with Reach Wellness's vision and financial backing, demonstrating a shared commitment to improving the treatment and support of Australia's first responders impacted by mental health conditions like PTSD.